![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 38, 26956-26961, September 17, 1999
From the Institute for Chemical Reaction Science, Tohoku
University, Sendai 980-8577, Japan
Nitric-oxide synthase (NOS) is composed of an
oxygenase domain having cytochrome P450-type heme active site and a
reductase domain having FAD- and FMN-binding sites. To investigate the
route of electron transfer from the reductase domain to the heme, we generated mutants at Lys423 in the heme proximal site
of neuronal NOS and examined the catalytic activities, electron
transfer rates, and NADPH oxidation rates. A K423E mutant showed no NO
formation activity (<0.1 nmol/min/nmol heme), in contrast with that
(72 nmol/min/nmol heme) of the wild type enzyme. The electron transfer
rate (0.01 min Nitric-oxide synthase
(NOS)1 produces nitric oxide
(NO) for a range of important biological functions (see Refs. 1-7 and
references therein). NOS consists of an oxygenase domain with a
thiol-coordinated heme active site similar to that of cytochrome P450
(P450), and an electron-transfer domain related to NADPH-cytochrome
P450 reductase which binds FMN and FAD. For NOS to catalyze efficient
monooxygenation reactions, the presence of effectors such as calmodulin
(CaM) and tetrahydrobiopterin (H4B) as well as the
formation of the homodimer are prerequisite. It is conceivable that CaM
plays an important role in arranging the protein structure for
efficient electron transfer to occur from the reductase domain to the
heme domain (8). H4B is bound to a site distant from the
L-Arg-binding site located on the heme distal side within
the oxygenase domain, based on the x-ray crystal structure of the
dimeric oxygenase domain of inducible NOS (iNOS) and endothelial NOS
(eNOS) (9-11). Another structurally important factor, consisting of a
cysteine-bound zinc center, was indicated by two groups (10, 11).
A recent report suggested an emerging role for H4B,
suggesting that it may deliver a second electron to the intermediate
Fe(II)-O2-L-Arg ternary complex for the
activation of molecular oxygen during P450-type monooxygenation at the
heme active site (12). Another role for H4B recently
proposed suggests that a non-heme iron-pterin complex is involved in
the activation of molecular oxygen during the monooxygenation of
L-Arg, functioning in a similar way to aromatic amino acid
hydroxylase (13). The x-ray crystal structure of eNOS also suggests
that a pterin radical is directly involved in the catalysis (10). Thus,
the first step of NO synthesis, monooxygenation of L-Arg to
NG-hydroxy-L-Arg (NHA), is a matter
of debate in regard to the role of H4B. The mechanism of
the second monooxygenation from the intermediate compound, NHA, to NO
and L-citrulline has also been controversial, although it
seems likely that the heme iron is directly involved in this process
(15-19).
Whichever mechanism is followed, introduction of electrons into the
oxygenase domain is necessary for the activation of molecular oxygen
during catalysis (20-23). If H4B is involved in the
introduction of the second electron to the heme active site (12), the
electron must initially reach H4B via the heme distal side
from NADPH per se or directly via the reductase domain.
Likewise, electron transfer via the heme distal side would be possible
if the non-heme iron-pterin complex is involved in the activation of
molecular oxygen for the monooxygenation of L-Arg (13), or
if a pterin radical is involved in the process (10). However, it seems
likely that electrons pass directly to the heme iron for the second
step, monooxygenation of NHA, since the heme iron seems certain to be the site for this process. Interestingly, a recent report proposed that
intermolecular electron transfer from the adjacent reductase domain to
the oxygenase domain occurs in the homodimer of iNOS (24). Previous
work in this laboratory suggested that basic amino acids such as Lys
and Arg on the proximal surface of microsomal P450s are important for
the interaction between the reductase and P450 for efficient electron
transfer to occur (25, 26). It is possible that similar interactions
are required for electron transfer to occur in the homodimer of NOS,
particularly in view of the structural rearrangement which probably
occurs at the reductase domain-heme domain interface on CaM binding.
In the present study, we mutated a moderately conserved basic amino
acid, Lys423 of neuronal NOS (nNOS), to several neutral and
acidic amino acids and studied the mutation effect on the catalytic
activity and electron transfer rate from NADPH to the heme. Note that
the 423 position is conserved as Lys for both nNOS and eNOS, while it is Asn for iNOS (Fig. 1). A K423E mutant
had no NO formation activity with either L-Arg or NHA as
substrate. This mutant also showed a very low electron transfer rate
from the reductase domain to the heme iron under both aerobic and
anaerobic conditions. Also, the heme of the K423E mutant proved
difficult to reduce by sodium dithionite. Thus, we suggest that
Lys423 is involved in catalysis, perhaps in regulating the
rate of electron transfer from the reductase domain to the heme active
site of nNOS.
Materials--
H4B was purchased from Schircks
Laboratories (Jona, Switzerland). Other reagents, which were from Wako
Pure Chemicals (Osaka, Japan), were of the highest guaranteed grade and
were used without further purification.
Preparation of Neuronal NOS--
Rat nNOS cDNA was kindly
gifted by Dr. S. H. Snyder (Johns Hopkins University School of
Medicine). nNOS was expressed in Saccharomyces cerevisiae
using the acid phosphatase promoter previously used for the expression
of cytochrome P450 1A2 (25-27). The oligonucleotide primers for the
mutations of Lys423 to Glu, Met, Leu, and Asn were
5'-CCAGTGGTCCGAGCTGCAGG-3',
5'-CAGTGGTCCATGCTGCAGGT-3', 5'-CAGTGGTCCCTGCTGCAGGT-3', and
5'-AGTGGTCCAATCTGCAGGTG-3', respectively. The polymerase
chain reaction-based mutageneses were performed using
oligonucleotide-directed dual amber long and accurate PCR kits (Takara
Shuzo, Kyoto, Japan).
Purification of wild-type and mutant nNOS enzymes were carried out
using 2',5'-ADP-Sepharose and calmodulin-Sepharose column chromatographies as described previously (28, 29). For all enzymes,
purified nNOS was more than 95% pure as judged by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis stained with Coomassie Blue
R-250 and by Western blot analysis. The purified and concentrated
enzyme was dialyzed against 50 mM Tris-HCl (pH 7.5) buffer
containing 4 µM H4B, 0.1 mM DTT,
0.1 mM EDTA, and 10% glycerol. The concentration of nNOS
was determined optically from the [CO-reduced] Enzyme Assay--
The rate of NO formation was determined from
the NO-mediated conversion of oxyhemoglobin to methemoglobin, monitored
at 401 nm using a methemoglobin minus oxyhemoglobin extinction
coefficient of 49 mM Optical Absorption Spectra--
Spectral experiments under
aerobic conditions were carried out on a Shimadzu UV-2500
spectrophotometer maintained at 25 °C by a temperature controller.
Anaerobic spectral experiments were conducted on a Shimadzu UV-160A
spectrophotometer maintained at 14 °C in a glove box under a
nitrogen atmosphere with an O2 concentration of less than
10 ppm. To ensure that the temperature of the solution was appropriate,
the cell was incubated for 10 min prior to spectroscopic measurements.
Titration experiments were repeated at least three times for each
complex. Regression analyses were performed and lines giving an optimum
correlation coefficient were selected. Linear least-squares fitting was
carried out on a Power Macintosh 6100/60AV personal computer using
DeltaGraphTM software as described previously (23, 25).
Experimental errors were less than 20%.
Crystal Structure--
The crystal structure coordinates of
bovine eNOS heme domain (10) were obtained through the WWW from the
Protein Data Bank. RasMac 2.6-ucb1.0 software was used to determine the
distance between Lys194 and Trp180 in eNOS.
We generated K423E, K423M, K423L, and K423N mutants. The Soret
spectral band of the resting Fe(III) form of the all mutants appeared
to consist of a mixture of the high spin and low spin complexes as
observed for the wild type enzyme (A and B in
Fig. 2). The Soret bands of the mutants
were moved to 395 nm and became narrower on addition of
L-Arg, similar to the wild type enzyme, suggesting that the
L-Arg-binding site was not altered by the mutation of the
proximal site of nNOS and that the spin state change still occurred as
normal. The lower part of Fig. 2 shows difference absorption spectra of
the Fe(II)-CO complexes of the wild type and K423E mutant purified from
the supernatant of the yeast crushed homogenized solution. No
absorption band around 420 nm ascribed the denatured complex, P420, was
observed for the K423E mutant as with the wild type enzyme (28, 29).
The K423M, K423L, and K423N mutants also generated in the present study
all had similar spectra.
Table I summarizes various kinetic
parameters associated with the catalysis of this enzyme, when
L-Arg is used as a substrate. The NO formation rate of
K423E was less than 0.1 nmol/min/nmol heme, in contrast with that of
the wild type enzyme (72 nmol/min/nmol heme). The K423M and K423L
mutants had relatively low NO formation activities, 18 and 25 nmol/min/nmol heme, respectively. In contrast, K423N had a similar
catalytic activity (78 nmol/min/nmol heme) to the wild type enzyme. We
also examined the NO formation rate of the Lys423 mutants
using NHA, the reaction intermediate, as the substrate (Table
II). When NHA was used, the NO formation
activity of the K423E mutant was 3 nmol/min/nmol of heme, whereas those
of the other mutants were between 52 and 78 nmol/min/nmol of heme,
which is comparable to that of the wild type enzyme (72 nmol/min/nmol of heme). These relatively high activities could be caused by the shunt
reaction with H2O2, a by-product of
O2 reduction on catalytic uncoupling (14-18, 20, 21).
However, this is unlikely in the presence of catalase, therefore,
it may indicate that the second step of the reaction (monooxygenation
of NHA) is less dependent on the supply of electrons to the heme iron
than the first step (monooxygenation of L-Arg). This is
consistent with the fact that monooxygenation of NHA requires only 1 electron equivalent per NO generated, whereas NO generation from
L-Arg requires 3 electron equivalents.
Crucial Role of Lys423 in the Electron Transfer of
Neuronal Nitric-oxide Synthase*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1) of the K423E on addition of excess NADPH
was much slower than that (>10 min
1) of the wild type
enzyme. From the crystal structure of the oxygenase domain of
endothelial NOS, Lys423 of neuronal NOS is likely to
interact with Trp409 which lies in contact with the heme
plane and with Cys415, the axial ligand. It is also exposed
to solvent and lies in the region where the heme is closest to the
protein surface. Thus, it seems likely that ionic interactions between
Lys423 and the reductase domain may help to form a flavin
to heme electron transfer pathway.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (40K):
[in a new window]
Fig. 1.
Amino acid sequences at the proximal site of
NOSs (1-7).
designates the amino acid residue mutated in this
study.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
[reduced]
difference spectrum using 
444-467 nm = 55 mM
1 cm
1. This 
value was
estimated by the pyridine hemochromogen method (28) assuming that one
heme is bound to one subunit of this enzyme.
1 cm
1 (1).
The NADPH oxidation rate was determined spectrophotometrically as an
absorbance decrease at 340 nm, using an extinction coefficient of 6.22 mM
1 cm
1. Unless otherwise
indicated, assays were carried out at 25 °C in 50 mM
Tris-HCl (pH 7.5) buffer containing 10 µM oxyhemoglobin, 0.1 mM NADPH, 5 µM each of FAD and FMN, 10 µg/ml CaM, 1 mM CaCl2, 100 units/ml catalase,
10 units/ml superoxide dismutase, 5 µM H4B, 5 µM DTT, and 0.05-0.1 µM nNOS in the
presence or absence of 0.5 mM L-Arg or NHA.
Cytochrome c reductase activity was determined by monitoring
the absorbance at 550 nm using an extinction coefficient = 21 mM
1 cm
1. Potassium ferricyanide
reductase activity was determined by monitoring the absorbance at 420 nm using an extinction coefficient = 1.2 mM
1 cm
1. The reductase
activities of the Lys423 mutants were essentially the same
as those of the wild type. The H2O2 generation
rate was measured by the formation of ferric thiocyanate under similar
conditions as described for the NO formation activity and NADPH oxidase
activity, but without catalase and superoxide dismutase present.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (41K):
[in a new window]
Fig. 2.
Optical absorption spectra
(upper) of Fe(III) complexes in the absence (red) and
presence (green, 1 min; blue, 6 min
after addition) of 0.5 mM L-Arg for the wild
type (A) and the K423E mutant
(B). Difference absorption spectra
(lower) of Fe(II)-CO complexes of the wild type
(C) and K423E mutant (D).
Kinetic parameters (nmol/min/nmol heme) of the Lys423 mutants
of nNOS in the presence of L-Arg
Kinetic parameters (nmol/min/nmol of heme) of the Lys423
mutants of nNOS in the presence of NHA
Since the low activity of the K423E mutant appeared to be associated
with the heme reduction rate and/or the electron transfer rate from
NADPH via FAD and FMN in the reductase domain to the heme iron, the
rate of the heme reduction on addition of excess NADPH was examined
under both aerobic and anaerobic conditions. Fig.
3 shows the Soret absorption spectral
changes of the wild type and K423E mutant in the presence of CO on
addition of NADPH under anaerobic conditions. The 0.5 µM
wild type nNOS quickly (in less than 0.5 min) showed a peak at around
445 nm on addition of 0.1 mM NADPH, while the K423E mutant
showed only a small peak at around 445 nm even after 40 min incubation
under the same conditions. A similar trend was seen under aerobic
conditions. Table I summarizes the rate of heme reduction in the
presence of NADPH for the other Lys423 mutants. All the
mutants generated in this study showed significantly slower rates of
heme reduction than the wild type enzyme.
|
It was also interesting to note that the intensity of the wild-type Fe(II)-CO complex caused by adding excess NADPH under anaerobic conditions reached up to about 50% of that caused by adding sodium dithionite. This intensity with excess NADPH never increased to the same intensity as with sodium dithionite even in the presence of L-Arg and H4B. The Lys423 mutants behaved similarily. This phenomenon may be caused by the slow disproportionation of electrons required for full reduction by NADPH, and/or the fact that the reduction potential of NADPH is not as negative as dithionite so that it is a less effective reducing agent even after equilibration. Under anaerobic conditions in the presence of NHA, the Soret intensity of the wild type Fe(II)-CO with NADPH was 60-70% of that with sodium dithionite for the wild type (not shown). For the Lys423 mutants, no essential difference between L-Arg and NHA solutions was observed. The heme reduction rate with NADPH in the presence of NHA was merely 10-20% higher than in the presence of L-Arg for the wild type. Similar increase of the reduction rate was observed for the Lys423 mutants.
In order to understand the coupling of electron transfer to NO formation, we obtained the NADPH oxidation rate during catalysis (Table I). The rates of NADPH oxidation of the wild type and the mutants compare well with the corresponding NO formation rates. Namely, both the wild type and the K423L and K423N mutants, which have large NO formation activities, showed relatively high NADPH oxidation rates, whereas both the K423E and K423M mutants, which have low NO formation activities, also had relatively low NADPH oxidation rates. In the presence of NHA, the NADPH oxidation rates of the K423M, K423L, and K423N mutants were comparable to that of the wild type enzyme, whereas that of the K423E mutant was lower (Table II). The electrons from NADPH may be used to generate H2O2 to a certain extent, which may then be used for propagating NHA monooxygenation via the shunt reaction. It should be also noted as a possibility that a significant amount of reducing equivalents leaked to form superoxide anion radicals.
During P450-type catalysis, H2O2 is formed when O-O bond cleavage is not coupled well to electron transfer (20-23). The H2O2 formation rates of the K423E and K423M mutants, which exhibit low catalytic activities with L-Arg, were higher than those of the wild type enzyme and the K423N and K423L mutants (Table I). The reciprocal relationships between catalytic activity and H2O2 formation rates for the wild type and Lys423 mutants were also observed in the P450 system.
It is difficult to obtain the redox potential of the heme iron of the
holoenzyme since FAD and FMN absorption bands overlap with the heme
absorption band (30). However, we estimated the relative reduction
ability of the heme iron of the mutant enzymes on addition of sodium
dithionite. Fig. 4 shows how the heme of the wild type and the K423E mutant were reduced by addition of the same
amount of sodium dithionite under anaerobic conditions. The 0.3 µM wild type heme was almost completely reduced in 3 min in the presence of CO by adding 40 µM sodium dithionite,
while only 15% of the K423E mutant heme was reduced even after 20 min following the same procedure. Thus, it appears that the heme of the
K423E is difficult to reduce by both sodium dithionite and NADPH.
|
If ionic interactions are important in the formation of protein-protein
complexes, determining protein conformation and catalytic activity,
changes in salt concentration should influence the enzyme's kinetic
parameters (31). Fig. 5 shows the effect
of KCl on the NO formation activities of the wild type enzyme and
Lys423 mutants. The NO formation activity of the wild type
enzyme increased by 1.8-fold when the KCl concentration was increased
up to 200 mM. However, the activity of K423N did not
essentially change even on adding up to 500 mM KCl. The
activities of K423M and K423L decreased by half on addition of 500 mM KCl.
|
In order to understand how mutations influence the monomer-dimer
equilibrium, we examined low-temperature SDS-polyacrylamide gel
electrophoresis and gel filtration column chromatography. Essentially
no change in the equilibrium was found when the mutant enzymes were
compared with the wild type (not shown).
| |
DISCUSSION |
|---|
|
|
|---|
The absorption spectrum of the Fe(II)-CO complex of P450 or P450-type heme proteins reflects the integrity of the heme active site structure in that the presence of a 420-nm peak indicates enzyme denaturation. Since all the Lys423 mutants we generated had normal Fe(II)-CO spectra, with no band around 420 nm, the Lys423 residue is unlikely to be directly involved in the binding of heme to the active site. If Lys423 were to directly contact the heme plane and/or the heme propionate, heme binding to the apoprotein would be expected to be destabilized if these interactions were disrupted by the mutations.
As can be seen in the amino acid sequence comparison (Fig. 1), Lys423 is not well conserved throughout the NOS isoforms. Lys423 of nNOS corresponds with Asn202 of iNOS. The K423N mutant of nNOS we generated in this study had similar catalytic activity to the wild type enzyme and its other kinetic parameters were comparable. Thus, there appears to be no significance in the lack of conservation of this residue in nNOS and iNOS.
The crystal structure of the oxygenase domain of bovine eNOS indicates
that the amino nitrogen of the axial ligand, Cys186
(Cys184 of human eNOS, Ref. 11), interacts with several
proximal site amino acids, including Gly188,
Arg189, and Trp180 via ionic or hydrogen bonds
(10). The proximal structure of nNOS is likely to be similar to that of
eNOS, in which case the axial ligand, Cys415, will interact
with Trp409 of nNOS. The crystal structure of eNOS also
indicates that Lys194, which corresponds with
Lys423 of nNOS, probably interacts with Trp180,
which corresponds with Trp409 of nNOS, via a hydrogen bond
over about 2.4 Å distance (with RasMac 2.6-ucb1.0 software) (Fig.
6). In the present study, the replacement
of Lys423 with acidic or neutral residues (Glu, Met, or
Leu) resulted in a clear decrease in the NO formation activity
observed. Therefore, these results suggest that ionic interactions or
hydrogen bonding between Lys423 and Trp409 in
the oxygenase domain or adjacent residues in the reductase domain are
tightly associated with NO formation and electron transfer from the
reductase domain. Thus, the disruption of these ionic interactions by
mutation of Lys423 markedly reduced the NO formation
activity and the rate of electron transfer from NADPH to the heme iron.
The K423N mutant retained NO formation activity, confirming its
compatibility with this position indicated by the sequence of iNOS.
Presumably, Asn is able to form similar contacts to Lys, recreating a
viable electron transfer route from the reductase domain to the heme.
In the crystal structure of the eNOS oxygenase domain, the heme is
clearly displaced to one side of the protein. The region in which the
heme lies closest to the solvent exposed surface of the domain includes the Lys194 residue (Lys423 in nNOS), which
crystallizes in direct contact with several water molecules. In fact,
the heme is only 6 Å from this residue and only 5 Å from the solvent
exposed surface. In view of this, it seems likely that
Lys423 may form direct contact with the reductase domain,
acting as the start of an electron transfer pathway also including the
aromatic residue Trp409 which would bridge the gap between
the heme and Lys423. As a matter of fact, the molecular
surface near the FMN-binding site of NADPH-cytochrome P450 reductase
has several acidic residues which are conserved in nNOS (Fig.
7) (32, 33). It is conceivable that these
acidic amino acids of the reductase domain interact with basic amino
acids of the oxygenase domain for effective electron transfer (Fig.
7).
|
|
Ionic interactions in the heme vicinity may also be important to control the redox potential of the heme iron maintaining an appropriate driving force for electrons to transfer to the heme iron (34). It was difficult, however, to obtain redox potentials for the mutant enzymes because the absorption bands of FAD and FMN hamper the monitoring of the heme absorption accompanying the redox change. However, the reduction rate of the K423E ferric heme by sodium dithionite appeared to be lower than that of the wild type enzyme under the same conditions. Thus, it is possible that the lowered NO formation activity and electron transfer rate of the K423E mutant is also associated with a change in the redox potential of the heme iron. However, dithionite may reduce the heme directly via an alternative pathway. As such, the slow reduction of the heme in the K423E mutant could be simply a consequence of charge repulsion between dithionite ion and the glutamic acid side chain.
Increasing the KCl concentration increases the rate of cytochrome c reduction by NADPH-cytochrome c reductase (35). Also, P450 monooxygenase activity increases with increasing KCl concentration when the P450:NADPH-P450 reductase molar ratio is 10 (36). Thus, it is not uncommon for protein-protein interactions to be stabilized at high concentrations of KCl and intermolecular electron transfer rates increased. The NO formation rate of the wild type enzyme increased with the KCl concentration (Fig. 5), similar to the results obtained elsewhere (31). Following the Lys423 mutations, this tendency was markedly changed. The salt (KCl) effect probably implies a possible direct solvent exposure of this area including Lys423. Therefore, it seems clear that the ionic interaction of Lys423 with other amino acids is important in catalyzing NO formation and in facilitating electron transfer from NADPH to the heme. Such a change in ionic strength dependence is characteristic of intermolecular electron transfer, but in the case of NOS this would involve interdomain or intersubunit electron transfer. However, if the domains involved retain a degree of relative conformational mobility, the same principles would apply. Intermolecular electron transfer across the interfacial surface between the oxygenase and adjacent reductase of the microsomal P450 system was found to involve the conserved Lys/Arg residues of the proximal surface which interact with Asp/Glu residues of the NADPH-P450 reductase surface (25, 32). A similar interaction appears to be involved in the case of nNOS.
The optical absorption intensity of the Fe(II)-CO complex caused by NADPH reduction (Fig. 3) was only about 50% of that induced by sodium dithionite in the presence of L-Arg. Similar observations are reported for wild-type iNOS (24) and a C331A mutant of nNOS (37). The intensity never reached the same level with sodium dithionite even in the presence of a large excess of NADPH under strict anaerobic conditions. It is conceivable that catalytically generated NO quickly binds to the reduced heme and hampers further binding of CO to the heme. However, this is unlikely under anaerobic conditions because NO formation would be negligible. It is also possible that electron transfer between reductase domains is necessary to aid full reduction, which would be a slow process. NADPH is only able to supply electrons in pairs, limiting the equilibration process severely. When reduced, the electrons will be shared according to the redox potentials of the various NOS cofactors, the equilibrium may be unattainable without rapid inter-subunit electron transfer or introduction of an electron transfer mediator. Dithionite possesses both a lower reduction potential and the ability to donate single electrons. Both factors may cause it to be more effective at reducing the NOS heme than NADPH.
In summary, it was found that Lys423 is very much involved
in the catalytic generation of NO and in electron transfer from NADPH to the heme iron. Based on the NADPH oxidation rate and the heme reduction rate of the Lys423 mutants, it appears that
Lys423 forms a key contact in the electron transfer route
from the FMN of the reductase domain to the heme of the oxygenase
domain via the proximal site.
| |
FOOTNOTES |
|---|
* This work was supported in part by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan for Priority Area (biometallics) (11116201) (to T. Shimizu) and the Ogura Science Foundation (to T. Shimanuki).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Institute for Chemical
Reaction Science, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai
980-8577, Japan. Tel.: 81-22-217-5604; Fax: 81-22-217-5604 (office) or
81-22-217-5664 (library); E-mail: shimizu@icrs.tohoku.ac.jp.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: NOS, nitric-oxide synthase; NO, nitric oxide; nNOS, neuronal NOS; iNOS, inducible NOS; eNOS, endothelial NOS; P450, cytochrome P450; NHA, NG-hydroxy-L-Arg; H4B, (6R)-5,6,7,8-tetrahydro-L-biopterin; CaM, calmodulin; DTT, dithiothreitol.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Feelisch, M., and Stamler, J. S. (eds) (1996) Methods in Nitric Oxide Research , John Wiley & Sons, Chichester |
| 2. | Ignarro, L., and Murad, F. (eds) (1996) Nitric Oxide, Biochemistry, Molecular Biology, and Therapeutic Implications , Academic Press, San Diego |
| 3. | Lancaster, J., Jr. (ed) (1996) Nitric Oxide, Principles and Actions , Academic Press, San Diego |
| 4. | Maines, M. D. (ed) (1996) Nitric Oxide Synthase, Characterization and Functional Analysis , Academic Press, San Diego |
| 5. | Moncada, S., Stamler, J., Gross, S., and Higgs, E. A. (eds) (1996) The Biology of Nitric Oxide, Part 5 , Portland Press, London |
| 6. | Stuehr, D. J. (1997) Annu. Rev. Pharmacol. Toxicol. 37, 339-359[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Masters, B. S. S. (1994) Annu. Rev. Nutr. 14, 131-145[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Matsuoka, A.,
Stuehr, D. J.,
Olson, J. S.,
Clark, P.,
and Ikeda-Saito, M.
(1994)
J. Biol. Chem.
269,
20335-20339 |
| 9. |
Crane, B. R.,
Arvai, A. S.,
Ghosh, D. K.,
Wu, C.,
Getzoff, E. D.,
Stuehr, D. J.,
and Tainer, J. A.
(1998)
Science
279,
2121-2125 |
| 10. | Raman, C. S., Li, H., Martasek, P., Kral, V., Masters, B. S. S., and Poulos, T. L. (1998) Cell 95, 927-937[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Fischmann, T. O., Hruza, A., Niu, X. D., Fossetta, J. D., Lunn, C. A., Dolphin, E., Prongay, A. J., Reichert, P., Lundell, D. J., Narula, S. K., and Weber, P. C. (1999) Nature Struct. Biol. 6, 233-242[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Bec, N.,
Gorren, A. C. F.,
Voelker, C.,
Mayer, B.,
and Lange, R.
(1998)
J. Biol. Chem.
273,
13502-13508 |
| 13. |
Perry, J. M.,
and Marletta, M. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11101-11106 |
| 14. | Groves, J. T., and Han, Y.-Z. (1995) in Cytochrome P450, Structure, Mechanism, and Biochemistry (Ortiz de Montellano, P. R., ed), 2nd Ed. , pp. 3-48, Plenum Publishing Corp., New York |
| 15. |
Korth, H.-G.,
Sustman, R.,
Thater, C.,
Butler, A. R.,
and Ingold, K. U.
(1994)
J. Biol. Chem.
269,
17776-17779 |
| 16. | Pufahl, R. A., Wishnok, J. S., and Marletta, M. A. (1995) Biochemistry 34, 1930-1941[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Claque, M. J., Wishnok, J. S., and Marletta, M. A. (1997) Biochemistry 36, 14465-14473[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Rusche, K. M., Spiering, M. M., and Marletta, M. A. (1998) Biochemistry 37, 15503-15512[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Abu-Soud, H. M., Presta, A., Mayer, B., and Stuehr, D. J. (1997) Biochemistry 36, 10811-10816[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Johnson, E. F., and Waterman, M. R. (1996) Methods Enzymol. 272, 1-430 |
| 21. | Ortiz de Montellano, P. R. (ed) (1995) Cytochrome P-450, Structure, Mechanism and Biochemistry , 2nd Ed. , Plenum Press, New York |
| 22. |
Porter, T. D.,
and Coon, M. J.
(1991)
J. Biol. Chem.
266,
13469-13472 |
| 23. |
Guengerich, F. P.
(1991)
J. Biol. Chem.
266,
10019-10022 |
| 24. |
Siddhanta, U.,
Presta, A.,
Fan, B.,
Wolan, D.,
Rousseau, D. L.,
and Stuehr, D. J.
(1998)
J. Biol. Chem.
273,
18950-18958 |
| 25. |
Shimizu, T.,
Tateishi, T.,
Hatano, M.,
and Fujii-Kuriyama, Y.
(1991)
J. Biol. Chem.
266,
3372-3375 |
| 26. | Mayuzumi, H., Sambongi, C., Hiroya, K., Shimizu, T., Tateishi, T., and Hatano, M. (1993) Biochemistry 32, 5622-5628[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Nakano, R.,
Sato, H.,
Watanabe, A.,
Ito, O.,
and Shimizu, T.
(1996)
J. Biol. Chem.
271,
8570-8574 |
| 28. |
Sagami, I.,
and Shimizu, T.
(1998)
J. Biol. Chem.
273,
2105-2108 |
| 29. | Sato, H., Sagami, I., Daff, S., and Shimizu, T. (1998) Biochem. Biophys. Res. Commun. 253, 845-849[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Presta, A., Weber-Main, A. M., Stankovich, M. T., and Stuehr, D. J. (1998) J. Am. Chem. Soc. 120, 9460-9465[CrossRef] |
| 31. |
Nishimura, J. S.,
Narayanasami, R.,
Miller, R. T.,
Roman, L. J.,
Panda, S.,
and Masters, B. S. S.
(1999)
J. Biol. Chem.
274,
5399-5406 |
| 32. |
Sevrioukova, I. F.,
Li, H.,
Zhang, H.,
Peterson, J. A.,
and Poulos, T. L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1863-1868 |
| 33. |
Wang, M.,
Roberts, D. L.,
Paschke, R.,
Shea, T. M.,
Masters, B. S. S.,
and Kim, J.-J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8411-8416 |
| 34. | Raag, R., and Poulos, T. L. (1989) Biochemistry 28, 917-922[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Shen, A.,
Christensen, M. J.,
and Kasper, C. B.
(1991)
J. Biol. Chem.
266,
19976-19980 |
| 36. |
Voznesensky, A. I.,
and Schenkman, J. B.
(1992)
J. Biol. Chem.
267,
14669-14676 |
| 37. |
Martasek, P.,
Miller, R. T.,
Liu, Q.,
Roman, L. J.,
Salerno, J. C.,
Migita, C. T.,
Raman, C. S.,
Gross, S. S.,
Ikeda-Saito, M.,
and Masters, B. S. S.
(1998)
J. Biol. Chem.
273,
34799-34805 |
This article has been cited by other articles:
![]() |
C.-C. Wei, Z.-Q. Wang, J. Tejero, Y.-P. Yang, C. Hemann, R. Hille, and D. J. Stuehr Catalytic Reduction of a Tetrahydrobiopterin Radical within Nitric-oxide Synthase J. Biol. Chem., April 25, 2008; 283(17): 11734 - 11742. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Panda, M. M. Haque, E. D. Garcin-Hosfield, D. Durra, E. D. Getzoff, and D. J. Stuehr Surface Charge Interactions of the FMN Module Govern Catalysis by Nitric-oxide Synthase J. Biol. Chem., December 1, 2006; 281(48): 36819 - 36827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kim, Z.-L. Wu, and F. P. Guengerich Analysis of Coumarin 7-Hydroxylation Activity of Cytochrome P450 2A6 using Random Mutagenesis J. Biol. Chem., December 2, 2005; 280(48): 40319 - 40327. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Garcin, C. M. Bruns, S. J. Lloyd, D. J. Hosfield, M. Tiso, R. Gachhui, D. J. Stuehr, J. A. Tainer, and E. D. Getzoff Structural Basis for Isozyme-specific Regulation of Electron Transfer in Nitric-oxide Synthase J. Biol. Chem., September 3, 2004; 279(36): 37918 - 37927. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, I. Sagami, and T. Shimizu Identification of Caveolin-1-interacting Sites in Neuronal Nitric-oxide Synthase: MOLECULAR MECHANISM FOR INHIBITION OF NO FORMATION J. Biol. Chem., March 5, 2004; 279(10): 8827 - 8836. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Craig, S. K. Chapman, and S. Daff Calmodulin Activates Electron Transfer through Neuronal Nitric-oxide Synthase Reductase Domain by Releasing an NADPH-dependent Conformational Lock J. Biol. Chem., September 6, 2002; 277(37): 33987 - 33994. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Rozhkova, N. Fujimoto, I. Sagami, S. N. Daff, and T. Shimizu Interactions between the Isolated Oxygenase and Reductase Domains of Neuronal Nitric-oxide Synthase. ASSESSING THE ROLE OF CALMODULIN J. Biol. Chem., May 3, 2002; 277(19): 16888 - 16894. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kobayashi, S. Tagawa, S. Daff, I. Sagami, and T. Shimizu Rapid Calmodulin-dependent Interdomain Electron Transfer in Neuronal Nitric-oxide Synthase Measured by Pulse Radiolysis J. Biol. Chem., October 19, 2001; 276(43): 39864 - 39871. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sagami, Y. Sato, S. Daff, and T. Shimizu Aromatic Residues and Neighboring Arg414 in the (6R)-5,6,7,8-Tetrahydro-L-Biopterin Binding Site of Full-length Neuronal Nitric-oxide Synthase Are Crucial in Catalysis and Heme Reduction with NADPH J. Biol. Chem., August 18, 2000; 275(34): 26150 - 26157. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sagami, S. Daff, and T. Shimizu Intra-subunit and Inter-subunit Electron Transfer in Neuronal Nitric-oxide Synthase. EFFECT OF CALMODULIN ON HETERODIMER CATALYSIS J. Biol. Chem., August 3, 2001; 276(32): 30036 - 30042. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||